...
首页> 外文期刊>Hypertension: An Official Journal of the American Heart Association >Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant HypertensionNovelty and Significance
【24h】

Renal Hemodynamics and Renal Function After Catheter-Based Renal Sympathetic Denervation in Patients With Resistant HypertensionNovelty and Significance

机译:抵抗性高血压患者基于导管的肾交感神经支配后的肾血流动力学和肾功能的研究及其意义

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Increased renal resistive index and urinary albumin excretion are markers of hypertensive end-organ damage and renal vasoconstriction involving increased sympathetic activity. Catheter-based sympathetic renal denervation (RD) offers a new approach to reduce renal sympathetic activity and blood pressure in resistant hypertension. The influence of RD on renal hemodynamics, renal function, and urinary albumin excretion has not been studied. One hundred consecutive patients with resistant hypertension were included in the study; 88 underwent interventional RD and 12 served as controls. Systolic, diastolic, and pulse pressure, as well renal resistive index in interlobar arteries, renal function, and urinary albumin excretion, were measured before and at 3 and 6 months of follow-up. RD reduced systolic, diastolic, and pulse pressure at 3 and 6 months by 22.7/26.6 mm Hg, 7.7/9.7 mm Hg, and 15.1/17.5 mm Hg ( P for all <0.001), respectively, without significant changes in the control group. SBP reduction after 6 months correlated with SBP baseline values ( r =?0.46; P <0.001). There were no renal artery stenoses, dissections, or aneurysms during 6 months of follow-up. Renal resistive index decreased from 0.691±0.01 at baseline to 0.674±0.01 and 0.670±0.01 ( P =0.037/0.017) at 3- and 6-month follow-up. Mean cystatin C glomerular filtration rate and urinary albumin excretion remained unchanged after RD; however, the number of patients with microalbuminuria or macroalbuminuria decreased. RD reduced blood pressure, renal resistive index, and incidence of albuminuria without adversely affecting glomerular filtration rate or renal artery structure within 6 months and appears to be a safe and effective therapeutic approach to lower blood pressure in patients with resistant hypertension.# Novelty and Significance {#article-title-35}
机译:肾抵抗指数增加和尿白蛋白排泄是高血压终末器官损害和涉及交感神经活动增加的肾血管收缩的标志。基于导管的交感神经去神经支配术(RD)提供了一种新的方法来减少抵抗性高血压患者的肾脏交感神经活动和血压。尚未研究RD对肾脏血液动力学,肾脏功能和尿白蛋白排泄的影响。连续一百名抵抗性高血压患者被纳入研究。 88例接受了介入性RD,12例作为对照。在随访3个月和6个月时以及在随访时,分别测量收缩压,舒张压和脉压,以及小叶间动脉的肾脏抵抗指数,肾功能和尿白蛋白排泄。 RD使3个月和6个月的收缩压,舒张压和脉压分别降低22.7 / 26.6 mm Hg,7.7 / 9.7 mm Hg和15.1 / 17.5 mm Hg(所有P均<0.001),对照组无明显变化。 6个月后SBP降低与SBP基线值相关(r =?0.46; P <0.001)。随访6个月内无肾动脉狭窄,夹层或动脉瘤。肾脏抵抗指数从基线的0.691±0.01降至3个月和6个月的0.674±0.01和0.670±0.01(P = 0.037 / 0.017)。 RD后平均半胱氨酸蛋白酶抑制剂C的肾小球滤过率和尿白蛋白排泄保持不变;然而,患有微量白蛋白尿或大量白蛋白尿的患者数量有所减少。 RD可以在6个月内降低血压,肾脏抵抗指数和白蛋白尿的发生率,而对肾小球滤过率或肾动脉结构没有不利影响,并且似乎是一种安全有效的降低顽固性高血压患者血压的方法。#新颖性和意义{#article-title-35}

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号